Update on treating schizophrenia disorders

Introduction: Despite novel aspects of treatment, the course of schizophrenia disorders includes an enduring remission only in a third of its cases. The development of guidelines offers evidence based advice to optimize treatment. However they are continuous subject of debate when considering new findings in literature and putting their content to clinical practice. Methods: The following narrative review displays guideline strategies of treatment with respect to novel discussions. Along with pharmaceutical treatment, current development in health care science and its aspects fort the impact of treatment are presented. Results: New guidelines stress the fact that preferring second generation antipsychotics has to be questioned. Modern treatment focuses on individual aspects of therapy indication and risk management rather than relying on general aspects of class distinction between antipsychotics. Despite their potential benefits for long term treatment depot formulations may be underrepresented in clinical practice.